If they do not announce in a timely manner, then someone who sold before the information was released may have a valid claim.
If they announce too soon and it fails then others may have a valid claim.
Would this not be a good predicament to find one biotech like Peregrine to be in?
It seems that eventually, there is something to announce...... this is exactly why I follow the puzzle pieces and the yellow brick road leads to the Emerald City.
Like Dorothy, SK and company now seemed to have taken the longer, more dangerous path.... though this story will also live on for generations to come.
It seems Emminent in the Emerald City of oncology, there will live Billions of people that outlive even the most healthiest Docetaxel control arm
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!